rs3808942

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000373827.6(ANK3):​c.97-111451G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.738 in 152,166 control chromosomes in the GnomAD database, including 41,728 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.74 ( 41728 hom., cov: 32)

Consequence

ANK3
ENST00000373827.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.186

Publications

8 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.875 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_001204404.2 linkc.64-111451G>A intron_variant Intron 1 of 43 NP_001191333.1
ANK3NM_001204403.2 linkc.97-111451G>A intron_variant Intron 2 of 43 NP_001191332.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000373827.6 linkc.97-111451G>A intron_variant Intron 2 of 43 1 ENSP00000362933.2
ANK3ENST00000503366.6 linkc.64-111451G>A intron_variant Intron 1 of 43 2 ENSP00000425236.1
ANK3ENST00000622427.4 linkn.64-111451G>A intron_variant Intron 1 of 32 2 ENSP00000483244.1

Frequencies

GnomAD3 genomes
AF:
0.738
AC:
112193
AN:
152048
Hom.:
41703
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.657
Gnomad AMI
AF:
0.753
Gnomad AMR
AF:
0.738
Gnomad ASJ
AF:
0.780
Gnomad EAS
AF:
0.737
Gnomad SAS
AF:
0.899
Gnomad FIN
AF:
0.732
Gnomad MID
AF:
0.756
Gnomad NFE
AF:
0.774
Gnomad OTH
AF:
0.740
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.738
AC:
112268
AN:
152166
Hom.:
41728
Cov.:
32
AF XY:
0.742
AC XY:
55213
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.657
AC:
27261
AN:
41492
American (AMR)
AF:
0.738
AC:
11278
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.780
AC:
2706
AN:
3470
East Asian (EAS)
AF:
0.736
AC:
3806
AN:
5172
South Asian (SAS)
AF:
0.898
AC:
4336
AN:
4830
European-Finnish (FIN)
AF:
0.732
AC:
7750
AN:
10592
Middle Eastern (MID)
AF:
0.748
AC:
220
AN:
294
European-Non Finnish (NFE)
AF:
0.774
AC:
52664
AN:
68012
Other (OTH)
AF:
0.740
AC:
1565
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1498
2996
4494
5992
7490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
846
1692
2538
3384
4230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.762
Hom.:
168351
Bravo
AF:
0.729
Asia WGS
AF:
0.782
AC:
2717
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.0
DANN
Benign
0.77
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3808942; hg19: chr10-62150848; API